Harald Hampel on CSF Markers of Neuronal Injury Drop When Dementia Arrives
COMMENT To investigate longitudinal dynamics of pathophysiological biomarkers across all AD stages is of paramount importance for the understanding of disease initiation, progression, and biomarker-guided, targeted drug development. Ideally, we should obtain ...